Lucid Diagnostics Inc. LUCD
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -48.54M | -52.26M | -45.01M | -58.01M | -53.29M |
| Total Depreciation and Amortization | 880.00K | 875.00K | 873.00K | 872.00K | 885.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.41M | 7.48M | 1.18M | 13.46M | 10.43M |
| Change in Net Operating Assets | -7.28M | -2.97M | -3.16M | -2.81M | -1.81M |
| Cash from Operations | -51.53M | -46.87M | -46.12M | -46.49M | -43.78M |
| Capital Expenditure | -304.00K | -315.00K | -319.00K | -197.00K | -405.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -304.00K | -315.00K | -319.00K | -197.00K | -405.00K |
| Total Debt Issued | 0.00 | 0.00 | 0.00 | 360.00K | 21.98M |
| Total Debt Repaid | -- | -- | -- | -- | -3.62M |
| Issuance of Common Stock | 22.51M | 49.48M | 49.10M | 58.67M | 58.67M |
| Repurchase of Common Stock | -21.00K | -17.00K | -17.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 22.49M | 49.47M | 49.08M | 59.03M | 77.03M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -29.34M | 2.28M | 2.64M | 12.35M | 32.84M |